Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05637840 · ClinicalTrials.gov registry record · NA
Study of Metabolic Content of Urine
A NA study of Metabolic Content of Urine, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05637840: Completed NA study of Metabolic Content of Urine, sponsored by University of Wisconsin, Madison.
NCT05637840 is a NA study of Metabolic Content of Urine that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05637840, a NA study of Metabolic Content of Urine, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to test the different components in urine and see if they can be matched to food, exercise and sleep that participants report. The researchers are trying to find out if urine would allow them to predict medical problems as they are happening. Participants are healthy volunteers who are willing to give urine samples on a daily basis, and can expect to be in the study for 28 days.
Primary Outcome
Changes in inflammation will be measured by hs-CRP via short-term sleep restriction.
Conditions Studied
Interventions
- OTHER Sleep restriction
- OTHER Urine sample
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2022-12-06 |
| Est. Completion | 2023-11-18 |
| Phase | NA |
What the finished NCT05637840 record still lists
NCT05637840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Metabolic Content of Urine appearing as the primary indexed condition, and to 2 interventions - of which Sleep restriction is the first listed.
NCT05637840 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05637840 about?
NCT05637840 is a clinical study titled "Study of Metabolic Content of Urine". The purpose of this research study is to test the different components in urine and see if they can be matched to food, exercise and sleep that participants report. The researchers are trying to find out if urine would allow them to predict medical problems as they are happening. Participants are he...
What is the current status of trial NCT05637840?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2022-12-06. Estimated completion is 2023-11-18.
What conditions does trial NCT05637840 study?
This clinical trial studies the following conditions: Metabolic Content of Urine.
What interventions are being tested in trial NCT05637840?
The interventions under investigation include: Sleep restriction (OTHER), Urine sample (OTHER).
Who is sponsoring clinical trial NCT05637840?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05637840 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05637840's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI